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ABSTRACT 
New series of Bis N’-(1H-benzimidazol-2-yl)-N-alkyl amidine derivatives 2a-e were synthesized starting from (1H-benzimidazol-
2-yl) iminoester 1 with two equivalents of ethane-1,2-diamine. The structures of compounds were elucidated by spectroscopic 
methods including IR, 1H NMR, 13C NMR, and 13C NMR Dept 135° of 2b, elemental analyses and mass spectral analysis. In the 
next step, the above mentioned compounds were screened for antioxidant activity. Their antioxidant activity was assessed using, 
the rapid and the most appropriate method, 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay. The results indicated 
that bis amidines 2a-e tested possess good antioxidant activity. Compounds 2c and 2e showed excellent antioxidant activity, while 
compounds 2a, 2d and 2b showed the lowest one. 
Keywords: Benzimidazole, Bis amidines, DPPH method, ethane-1,2-diamine , Iminoesters.  
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INTRODUCTION 
Free radicals are among the main products of lipid 
oxidation and have been involved in over hundred 
diseases including cancer, atherosclerosis and arthritis
1
. 
Antioxidants are important compounds that reduce or 
neutralize the free radicals, thus protecting the cells 
from oxidative injury
2
. At present various research 
groups worldwide are directed towards the 
identification of new antioxidants to prevent radical-
induced damage. The bis amidines, form an important 
class of compounds, are well known antiviral and 
antitumor
3
. Over the years, the bis amidines moiety 
have become an important class of heterocyclic 
compounds in organic synthesis due to their various 
biological properties. It is well known that bis amidines 
derivatives have therapeutic applications. Thus, there 
are various drugs incorporating in their structure used as 
antidegenerative 
4
 ,anti-inﬂammatory, antitumor5, 
antimicrobial
6
, antiparasitic
7
, antibacterial
8
, 
antiprotozoal
9
, antimalarial 
10
, anticancer
11
, anti HIV
12
, 
antidegenerative
13
, and urokinase inhibitor activities
14
 
are well documented in literature. In continuation of 
search on potent molecules exhibiting antioxidant 
activities we have synthesized a new series of of Bis 
N’-(1H-benzimidazol-2-yl)-N-alkylamidine derivatives 
and screened them for antioxidant activity which we 
wish to report in this paper. 
2. MATERIALS AND METHODS 
2.1. Materials 
Iminoester 1 was synthesized and purified by a reported 
method
15
. All the chemicals were taken sigma Aldrich 
campany. Other chemicals used were of analytical 
reagent grade without further purification. 
IR  spectra  were  recorded  with  a  Fourier  Transform  
Infrared Spectrometer (FT- IR 200).
1
H, 
13
C NMR and 
13
C NMR dept 135° spectra were recorded with  
(CD3)2SO as the  solvents containing  TMS on a  Brüker 
300  MHz spectrometer (USA).  The  chemical  shifts  
were  reported  in  δ  values  relative  to  TMS  (internal 
reference).  For  the 
1
H  NMR,  the  multiplicities  of  
signals  are  indicated  by  the  following abbreviations: 
s : singlet, d: doublet, t: triplet, q: quartet,  m:  multiplet. 
Melting points (m.p.) were obtained using a Buchi 
melting point apparatus. Elemental microanalysis was 
performed on a Perkin - Elmer CHN-2400 analyzer 
apparatus. The electron spray ionization (ESI) positive 
MS spectra were recorded on a Brüker Daltonics LC–
MS spectrometer (USA). 
2.2. General procedure for synthesis of Bis amidine 
N’-(1H-benzimidazol-2-yl)-N-alkyl derivatives 
Ethane-1.2-diamine (2 mmol) was added to a solution 
of iminoesters 1 (4 mmol) in ethanol (15 mL). The 
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reaction mixture was stirred and heated under reflux for 
24 h. The solvent was removed under vacuum, and the 
resulting solid was filtered off, dried and crystallized 
from a mixture of chloroform and dioxane (v/v 7:3) to 
give (2a-e). 
2.3 Antioxidant activity 
DPPH radical scavenging assay 
 The free radical scavenging activity of bis amidines 
derivatives 2a-e was evaluated using DPPH (1,1-
diphenyl-2- picrylhydrazyl) colorimetric method
16
. 
Although a number of methods are available for 
determination of the antioxidant activity, the DPPH 
method is very common, rapid and has been shown to 
be one of the most appropriate methods
17, 18
.
 
Different 
concentrations (5, 10, 20 and 40 µg/mL) of test 
compounds in dimethyl sulfoxide (DMSO) were 
prepared. In clean and labeled test tubes, the compound 
solution (1.0 mL) was added to the methanolic DPPH 
solution (2.0 mL, 0.1 mM) then the mixture was kept in 
the dark for 15 min, and the optical density was 
measured at 517nm using UV-Visible 
Spectrophotometer. The absorbance of the DPPH 
control was also noted. The percent scavenging activity 
was calculated using the following formula: inhibition 
(%) = 100*[(Abscontrol -Abscompound) ⁄Abscontrol]. The 
concentration of bis amidines derivatives providing 
50% inhibition (IC50) was calculated from the graph of 
the plot of inhibition percentage against bis amidines 
concentration (μg/mL)19. The synthetic antioxidant 
reagent butylated hydroxytoluene (BHT) was used as 
positive control and all tests were carried out in 
triplicate. 
Statistical analysis 
Statview v.5.0.1 software (SAS Institute, Cary, NC) 
was used for all statistical analyses. The significant 
difference of means were compared using analysis of 
variance (ANOVA) followed by Fisher’s PLSD tests. 
All the analyses were carried out in triplicate 
measurements and mean values were used for the 
statistical analysis. Differences were considered 
statistically significant if P< 0.05. 
3. RESULT AND DISCUSSION 
3.1 General procedure for synthesis Bis N’-(1H-
benzimidazol-2-yl)-N-alkylamidine derivatives 
Treatment  of  (1H-benzimidazol-2-yl)  iminoesters 1 
with two equivalents  of  ethane-1,2-diamine under 
reflux  of  ethanol  for  24h  afforded  the  Bis N’-(1H-
benzimidazol-2-yl)-N-alkylamidine derivatives 2a-e in 
good yields (scheme1).   
 
 
2a: R
1
=R
2
=CH3, 2b: R
1
=R
2
=CH2-CH3, 2c: R
1
=R
2
= C6H5-, 2d: R
1
=CH3, R
2
=CH2-CH3, 2e: R
1
=CH3, R
2
=C6H5- 
Scheme 1: Synthesis of Bis N’-(1H-benzimidazol-2-yl)-N-alkylamidine derivatives 
 
The structures of all synthesized compounds 2a-e were 
proven by IR, 
1
H NMR, 
13 
C NMR, elemental analysis 
and MS spectral data. The formation of compounds 2a-
e was confirmed by the IR spectra showing a band in 
the region of 1626-1650 cm
-1
 assigned to the C=N 
groups and another band in the region 3440-3387 cm
-1
 
corresponding to NH if benzimidazole moiety. The IR 
spectra of  bis amidines derivatives 2a-h exhibit a new 
absorption band at 3200-3150 cm
-1 
attributed to NH 
groups introduced by ethane-1,2-diamine. 
The 
1
H NMR spectrum of compounds  2a-e  revealed 
the disappearance of a signal specific to the ethoxy 
groups and the presence of new peaks assigned to the 
CH2 moiety in the  form of  multiplets  in the region δ 
3.10 ppm- δ 3.90 ppm.   
The 
13
C NMR revealed the signal of the different 
carbons and confirmed the formation of compounds 
2a-e.The 
13
C NMR dept 135° spectrum of compound 
2b   gives positive signals (singlet) for CH3 groups at δ 
11.6 ppm - δ 12.2 ppm and gives negatives signals 
(singlet) for CH2- group at δ 5.5 ppm-δ 29 ppm and δ 
38 ppm-δ 41 ppm for CH2 introduced by ethane-1,2-
diamine. We can conclude that Bis N’-(1H-
benzimidazol-2-yl)-N-alkylamidine 2a-e are not 
symmetrical. 
Interpretation 
Compound 2a: Yield: 63%, m.p.: 270°C,  IR (FT - IR 
200, ν   (cm-1))  ν = 3399 (NHbenzimidazole),  ν = 3120 
(NH),  ν= 1632 (C=N).1H NMR (DMSO-d6)  δ ; 1.51 
(s, 3H, C H3), 1.32 (s, 3H, CH3), 3.74 (m, 2H, CH2), 
3.82 (m, 2H, CH2), 5.72 (broad s, 2H, NH), 6.91(board 
s, 2H, NHbenzimidazole), 6.25-7.27(m, 8Haromatic).
13
C NMR 
(DMSO-d6) δ ; 25.71, 176.13, 162.90, 46.25, 47.93, 
168.32, 24.74, 161.05, 117.20- 143.63. Anal. Calcd. 
N
N
H
N O - C H
2
- C H
3
R
1
NH
2
N H
2
2
N
N
N
N
N
R
N
N N
R
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H
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For C20H22N8 (%):  C, 64.15; H, 5.92; N, 29.93. Found: 
C, 64.20; H, 5.96; N, 29.95. ESI-MS [M+1]
+
: m/z = 
375 
Compound 2b: Yield: 58%, m.p.: 266°C, IR (FT- IR 
200, ν (cm-1)) ν =3410 (NHbenzimidazole), ν = 3145(NH), 
ν= 1635(C=N). 1H NMR (DMSO-d6):  δ; 2.46 (q, 
3
JHH=  6.0 Hz, 2H,  CH2), 1.21 (t,
3
JHH = 6.0 Hz, 3H, 
CH3), 3.34 (m, 2H, CH2), 3.48 (m, 2H, CH2), 2.13 (q, 
3
JHH= 6.0 Hz, 2H, CH2), 1.09 (t, 
3
JHH =  6.0 Hz, 3H, 
CH3), 7.32 (board s, 2H,  NHbenzimidazole ),  6.12 (board  
s, 2H,  NH),  6.84-7.72  (m, 8Haromatic ).
13
C NMR 
(DMSO-d6):  δ ;  12.22,  29.07,  174.23,  157.73,  
38.36,  41.95,  166.71,  25.52,  11.63, 155.50,  111.81- 
138.72.
13
C NMR  dept  135°  (DMSO- d6):  δ ; 11.63, 
12.22,  25.52, 29.07, 38.36, 41.95.Anal. Calcd. For 
C22H26N8 (%):   C, 65.67; H, 6.51; N, 27.84. Found:  C, 
65.70; H, 6.49; N, 27.82.ESI-MS [M+1]
+
: m/z = 403. 
Compound 2c: Yield: 60%, m.p.: 280°C, IR (FT- IR 
200, ν (cm-1)) ν = 3440 (NHbenzimidazole), ν = 3150 (NH), 
ν = 1650(C=N). 1H NMR (DMSO-d6):  δ; 3.75  (m, 
2H,  CH2), 3.90  (m, 2H,  CH2),  5.20 (board s, 2H, 
NH), 11.31 (board s, 2H, NHbenzimidazole ), 7.33- 7.99 (m, 
18 H aromatic).
13
C NMR (DMSO- d6):  δ ;  156.70, 
167.34,  36.23,  44.92,  164.80,  154.71,  109.80- 
143.84.  Anal.  Calcd.  For C30H26N8 (%):   C, 72.27; H 
5.26; N, 22.47. Found: C, 72.25; H, 5.27; N, 22.49. 
ESI-MS [M+1]
+
: m/z = 499. 
Compound 2d: Yield: 68%, m.p.: 240°C, IR (FT- IR 
200,  ν (cm-1))  ν = 3420 (NHbenzimidazole), ν =  3148 
(NH),  ν=  1626(C=N).1H  NMR  (DMSO- d6):  δ; 2.16 
(s, 3H, CH3), 1.18 (t,
3
JHH = 9.0 Hz, 3H, CH3), 2.67 (q, 
3
JHH= 9.0 Hz, 2H, CH2), 3.48 (m, 2H,  CH2),  3.27 (m, 
2H, CH2), 4.47 (board  s, 2H,  NH),  10.82  (board  s, 
2H, NHbenzimidazole ), 6.84-7.80 (m,  8 Haromatic ).
13
C 
NMR  (DMSO- d6):  δ ;  22.51, 161.95, 175.06, 37.82, 
41.66, 173.45, 25.10, 9.98, 155.31, 111.40-138.46. 
Anal. Calcd. For C21H24N8 (%):  C, 64.93;   H, 6.23; N, 
28.84. Found: C, 64.91;   H, 6.24; N 28.85. ESI-MS 
[M+1]
+
: m/z = 389. 
Compound 2e: Yield: 51%, m.p.: 230°C, IR (FT- IR 
200, ν (cm-1))  ν= 3387(NHbnzimidazole), ν = 3130(NH),  
ν=1640 (C=N).1H NMR (DMSO-d6): δ; 1.86 (s, 3H, 
CH3), 3.46 (m, 2H, CH2), 3.10 (m, 2H,  CH2), 5.42 
(board s, 2H,  NH), 10.60 (board s,2H,  NHbenzimidazole),  
6.24-7.25 (m, 13Haromatic ).
13
C NMR  (DMSO- d6):  
δ22.40,  157.08,  163.78,  42.34,  43.64,  170.49,  
155.11,  111.51- 137.90.  Anal.  Calcd.  For C25H24N8 
(%):  C, 68.79;   H, 5.54; N, 25.67. Found: C, 68.80;   
H, 5.56; N, 25.69. ESI-MS [M+1]
+
: m/z = 437. 
3.2 Antioxidant activity 
In this study, antioxidant activity of the synthesized 
compounds 2a-e and the standard (BHT) were assessed 
on the basis of the radical scavenging effect of the 
stable DPPH free radical assay (Scheme2)  
 
Scheme 2: The probable mechanism for the reaction 
of compounds 2a-e with DPPH radical 
 
Figure 1 shows free radical scavenging activity of Bis 
N’-(1H-benzimidazol-2-yl)-N-alkyl amidine der. at 
different concentrations, the radical scavenging activity 
was observed to increase with the dose of compound 
and standard 
 
Figure 1: Scavenging activity of the synthesized Bis 
N’-(1H-benzimidazol-2-yl)-N-alkylamidine 
derivatives (2a-e) compared with BHT as standard 
The IC50 values represent the concentration at which 
50% of DPPH radical are inhibited. A lower IC50 value 
indicates a higher DPPH free radical scavenging 
activity. IC50 values of Bis amidine derivatives 2a-e 
and the reference compounds are given in Table 1.
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Table 1: Bis N’-(1H-benzimidazol-2-yl)-N-alkylamidine derivatives and their antioxidant activity 
Entry            Structure 
 
Compounds DPPH Radical scavenging activity 
(IC50 µg/mL) (mean ± SEM) 
 
1 
 
 
2a 
 
18.40* ± 0.15 
 
2 
 
 
2b 
 
11.08* ± 0.12 
 
3 
 
 
2c 
 
1.52* ± 0.03 
 
4 
 
 
2d 
 
14.83* ± 0.11 
 
5 
 
 
2e 
 
2.04* ± 0.02 
 
 
 
6 BHT  4.87* ± 0.51 
SEM – standard error of mean.  
*significantly different (p < 0.0001) 
 
According to our results, it is interesting to note that all 
the synthesized compounds 2a-e displayed a radical 
scavenging activity by hydrogen donation (hydrogen 
benzimidazolic and hydrogen amidic). Indeed, 2c and 2e 
with phenyl group exhibited an antioxidant higher 
activity as suggested by its low IC50 (1. 52 and 2. 04 
μg/mL, respectively). 
Whereas, remaining compounds 2a, 2d and 2b are 
showing lower scavenging activity when compared to 
standard BHT. The introduction of methyl and ethyl 
group in the remaining compounds led to a considerable 
reduction of the radical scavenging activity as revealed 
by the significantly higher IC50 value (18.40μg/mL, 
14.83μg/mL, 11.08 μg/mL respectively). These results 
indicate that the nature of substituent R
1
 and R
2
 in bis 
amidines moiety is very pivotal and affects the related 
radical scavenging activity. The scavenging effect of Bis 
N’-(1H-benzimidazol-2-yl)-N-alkyl amidine derivatives 
and the standard on the DPPH radical decreased in this 
order: 2c >>2e >>BHT>>2a>>2d>>2b. 
In the current study the Bis N’-(1H-benzimidazol-2-yl)-
N-alkyl amidine derivatives were most efficient towards 
DPPH than drugs reported in other studies. In fact, N, 
N'-diphenylbenzamidine  and N, N'-
diphenyldodecamidine exhibited an antioxidant activity 
with an IC50= 8.10 and 97,42 µg/mL respectively
20
. The 
maximum inhibition effectiveness rates of 2-methyl 
benzimidazole were 99.88% at 400 µg/mL
21
. 
Hydrazinecarbothioamides inhibited the DPPH activity 
with an IC50 = 39.39 µg/mL
22
. 
CONCLUSION 
Five Bis N’-(1H-benzimidazol-2-yl)-N-alkylamidine 
derivatives 2a-e were synthesized successfully and were 
subjected to investigation for their antioxidant activity in 
vitro towards DPPH. The results indicated the potential 
antioxidant properties of Bis amidines derivatives, and 
that the compound with phenyl group substituent on the 
2c and 2e exhibited a significant radical scavenging 
activity on DPPH assay compared with the standard 
antioxidant BHT. These findings suggest that these 
molecules might serve as interesting compounds for the 
development of new antioxidant agents and might be 
used in many diseases. 
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